We are live on ! Find out more
NEPH icon

Nephros

8 hedge funds and large institutions have $2.09M invested in Nephros in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3.37% more ownership

Funds ownership: 0%3.37% (+3.4%)

Holders
8
Holders Change
+8
Holders Change %
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SAM
1
Southpaw Asset Management
Connecticut
$601K +$541K +73,810 New
ISL
2
Ingalls & Snyder LLC
New York
$530K +$482K +65,789 New
Millennium Management
3
Millennium Management
New York
$313K +$282K +38,521 New
William Blair & Company
4
William Blair & Company
Illinois
$276K +$251K +34,249 New
BRWA
5
B. Riley Wealth Advisors
Florida
$211K +$192K +26,132 New
Goldman Sachs
6
Goldman Sachs
New York
$156K +$142K +19,418 New
LTFS
7
Ladenburg Thalmann Financial Services
Florida
$2K +$1.5K +205 New
UBS Group
8
UBS Group
Switzerland
+$154 +21 New

NEPH Hedge Fund Activity: Q3 2019 in Review

8 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q3 2019, worth a combined $2.09M.

Buyers outnumbered sellers: 8 funds opened new NEPH positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Southpaw Asset Management, opening a new position worth an estimated $541K.

  • 8 institutional investors held Nephros (NEPH) as of Q3 2019, up from 0 in Q2 2019.
  • Funds reported $2.09M of Nephros stock for Q3 2019.
  • 8 funds opened new Nephros positions in Q3 2019 and 0 closed out, a net change of +8 holders.
  • The largest Nephros buyer in Q3 2019 was Southpaw Asset Management, an estimated $541K added.

Based on aggregated 13F filings for Q3 2019.